Table of Contents
1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s five forces model
4.1.1 Bargaining Power of suppliers
4.1.2 Bargaining Power of Customer
4.1.3 Intensity of Competitor’s
4.1.4 Threat of New Entrants
5 India CRO Market, by Service Type
5.1 Introduction
5.1.1 Clinical trials
5.1.2 Product Development
5.1.3 Process Development
5.1.4 Post-Marketing Surveillance
5.1.5 Quality Monitoring
5.1.6 Others
6 India CRO Market, by Therapeutic Application
6.1 Introduction
6.1.1 Oncology
6.1.2 Cardiovascular
6.1.3 Neurology
6.1.4 Nephrology and Urology
6.1.5 Cardiovascular
6.1.6 Others
7 India CRO Market, by End User
7.1 Introduction
7.1.1 Pharmaceutical/biopharmaceutical companies
7.1.3 Medical devices Companies
7.1.4 Academic Institutes
8 India CRO Market, by Country
8.1 Introduction
8.2 North India
8.3 South India
8.4 East India
8.5 West India
8.6 Central India
9 Company Landscape
9.1 Introduction
9.1.1 Mergers Acquisitions
9.1.2 Collaborations
9.1.3 Release/New Product Launches
9.1.4 Other (Expansion, Updates, Partnership)
10 Company Profile
10.1 Quintiles IMS Holdings, Inc.
10.1.1 Company Overview
10.1.2 Product/Business Segment Overview
10.1.3 Financials
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Syngene, Pharmaceutical Product Development, LLC
10.2.1 Overview
10.2.2 Product/Business Segment Overview
10.2.3 Financials
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Siro Clinpharm
10.3.1 Overview
10.3.2 Product/Business Segment Overview
10.3.3 Financials
10.3.4 Key Developments
10.3.5 SWOT Analysis
10.4 VIMTA, Bilcare Limited
10.4.1 Overview
10.4.2 Product/Business Segment Overview
10.4.3 Financials
10.4.4 Key Developments
10.4.5 SWOT Analysis
10.5 Aizant Drug Research Solutions Private Limited
10.5.1 Overview
10.5.2 Product/Business Segment Overview
10.5.3 Financials
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 Piramal Pharma Solutions
10.6.1 Overview
10.6.2 Product/Business Segment Overview
10.6.3 Financials
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Synapse Labs Pvt Limited
10.7.1 Overview
10.7.2 Product/Business Segment Overview
10.7.3 Financials
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 Eurofins Scientific
10.8.1 Overview
10.8.2 Product/Business Segment Overview
10.8.3 Financials
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.9 Laurus Labs., Neuland Laboratories Ltd
10.9.1 Overview
10.9.2 Product/Business Segment Overview
10.9.3 Financials
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.10 PAREXEL International Corporation
10.10.1 Overview
10.10.2 Product/Business Segment Overview
10.10.3 Financials
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.11 Others
11 Appendix
List of Tables
TABLE 1 INDIA CRO MARKET, 2020-2032 (USD MILLION)
TABLE 2 INDIA CRO MARKET, BY SERVICE TYPE, 2020-2032 (USD MILLION)
TABLE 3 INDIA CRO MARKET, BY THERAPEUTIC APPLICATION, 2020-2032 (USD MILLION)
TABLE 4 INDIA CRO MARKET, BY END USER, 2020-2032 (USD MILLION)
TABLE 5 INDIA CRO MARKET, BY REGION, 2020-2032 (USD MILLION)
List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 INDIA CRO MARKET, BY SERVICE TYPE
FIGURE 4 INDIA CRO MARKET, BY THERAPEUTIC APPLICATION
FIGURE 5 INDIA CRO MARKET, BY END USER
FIGURE 6 INDIA CRO MARKET, BY REGION
FIGURE 7 INDIA CRO MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
